Medical research

Researchers overcome a vexing problem in vaccine research

Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published ...

HIV & AIDS

Training human antibodies to protect against HIV

During HIV infection, the virus mutates too rapidly for the immune system to combat, but some people produce antibodies that can recognize the virus even two years after infection. With an eye towards developing a vaccine, ...

Diseases, Conditions, Syndromes

Promising MERS coronavirus vaccine trial in humans

Researchers at the German Center for Infection Research (DZIF) have reported on a safety trial of a promising vaccine for MERS coronavirus. According to their study, published in The Lancet Infectious Diseases, vaccination ...

Medical research

Strengthening fragile immune memories to fight chronic infections

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the ...

Other

Drugmaker GSK buys US vaccine firm for up to $3.3 bn

British drugmaker GlaxoSmithKline on Tuesday snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm.

Medical research

A nanomaterial path forward for COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the ...

page 9 from 35